Changes in recreational drug use, reasons for those changes and their consequence during and after the COVID-19 pandemic in the UK
File(s)
Published version
Author(s)
Type
Journal Article
Abstract
Changes in drug use in the general population during the COVID-19 pandemic and their long-term consequences are not well understood. We employed natural language processing and machine learning to analyse a large dataset of self-reported rates of and reasons for drug use during the pandemic, along with their associations with anxiety, depression and substance use problems post-pandemic. Our findings revealed a transient decrease in drug use at the pandemic's peak, primarily attributed to reduced social opportunities. Conversely, some participants reported increased drug use for self-medication, boredom, and lifestyle disruptions. While users of psychedelics and MDMA had anxiety and depression rates similar to non-users, users of opioid agonists and depressants—representing one in ten active drug users—reported greater mental health challenges post-pandemic. These results suggest that a subset of active drug users with distinct profiles faces elevated risks, particularly for anxiety and depression, and may benefit from targeted support.
Date Issued
2025-07-01
Date Acceptance
2025-04-01
Citation
Comprehensive Psychiatry, 2025, 140
ISSN
0010-440X
Publisher
Elsevier
Journal / Book Title
Comprehensive Psychiatry
Volume
140
Copyright Statement
© 2025 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
License URL
Identifier
10.1016/j.comppsych.2025.152598
Publication Status
Published
Article Number
152598
Date Publish Online
2025-04-15